Advanstar Communications
Heather Onorati is a contributing writer for Dermatology Times.
May 18, 2020
A third-year resident in the department of dermatology at the University of California, Irvine has kicked off a passion project turning discarded sterilization wrap into face masks with a high filter efficiency. She hopes these will fill a need as well as reserve N95 masks and surgical masks for those procedures that they are designated.
April 23, 2020
A biodegradable oral adhesive patch demonstrated significant improvement in patients with oral lichen planus (OLP), according to AFYX Therapeutics, which reported the phase 2b trial results April 22.
March 31, 2020
Governments and the scienti fic community are racing to identify new and existing drugs that might help flatten the curve and save lives. Read from experts as they discuss the latest news and research surrounding possible treatments for COVID-19.
March 25, 2020
Experts sent a letter to the White House Coronavirus Task Force March 24, outlining concerns about a growing shortage of medications required for managing patients with lupus and rheumatoid arthritis after President Donald Trump said in a March 19 press conference that the anti-malaria drug hydroxychloroquine could treat COVID-19.
March 20, 2020
As the number of patients infected with COVID-19 continues to rise, several experts are relaying data they say may save lives and change the course of this pandemic. According to Drs. George Martin, Ted Rosen, Sheila Fallon-Friedlander, Albert Yan, and James Treat, recent data provides evidence of the use of HCQ, its dosing, as well as epidemiology insights that will serve all healthcare practitioners in the fight against the novel coronavirus, COVID-19.
As the national pandemic continues to escalate, the American Academy of Dermatology is actively compiling resources related to the novel coronavirus to support its members and their practices.
March 19, 2020
The American Academy of Dermatology (AAD) has issued interim recommendations for practitioners to balance the risk of immunosuppression with the risk of disease flare amid COVID-19 pandemic.
January 17, 2020
Risankizumab (SKYRIZI, AbbVie), outperformed secukinumab (Cosentyx, Novartis) in a head-to-head phase 3 study comparing the two treatments in adult patients with moderate to severe plaque psoriasis, according to data released by the company Jan. 14.
November 14, 2019
By the end of a three-day weekend, five of the teams at Hacking Dermatology's 2019 Hackathon walked away with $5,000 each. Learn more about the collaboration that took place and the solutions each team developed to solve pressing problem areas in dermatology.
April 05, 2019
